Miguel Borregón-Rivilla

8PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2026
Pneumocystis jirovecii pneumonia and prophylaxis in patients with solid tumours: a narrative review.

|Aug 29, 2025
Adding Docetaxel to Tepotinib to Overcome Oligoprogression in MET Exon 14 Skipping-Mutated NSCLC When Local Therapy Is Unfeasible: A Case Report.

David Sánchez García, Beatriz Grau Mirete, Paula Rodríguez Payá

|Jun 02, 2025
Previous history of solid tumor in patients presenting tuberculosis: a multicenter retrospective study in a low-tuberculosis-incidence area.

Miguel Borregón, Paula Rodríguez, Beatriz Grau

|Dec 05, 2024
Potential Negative Impacts of the CCI4EU Initiative on Spain.

Javier David Benitez Fuentes, Asia Ferrandez Arias, Miguel Borregon Rivilla

|Mar 22, 2024
Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy.

Miguel Borregón, David Sánchez, Elia Martínez

Pageof 2